The use of alternative proteins in food is a major trend in the food industry as feeding the world and sustainability are major drivers for food ingredient and food producers. NIZO focuses on relevant aspects of technologies that enable this transition namely: protein technology, processing technologies, food grade fermentation technologies and the health aspects.
The market for probiotics and live biotherapeutic products continues to grow, as we increase our understanding of how they can improve health. Probiotic and pharmaceutical companies are looking for ways to use the naturally occurring bacteria in our bodies to amend dysbiosis of the gut, skin and more. Then they must get their products to market, quickly and cost-effectively. But there are many challenges that will define a company’s success or failure – especially when working with living organisms, that don’t always behave the way we want. In this webcast, NIZO's multidisciplinary and multi-stage approach in the probiotic journey, from discovery to health benefit substantiation, will be explained.
We are facing challenges in the world, which strongly drive the innovation of foods. One of the drivers is the increasing demand from consumers for more sustainable food products. Changing from animal-based proteins towards plant-based proteins can increase the sustainability of foods. For this, innovations are necessary as animal-based proteins cannot be directly replaced by plant-based proteins due to different characteristics. Fermentation can therefore be used as a powerful tool to alter these characteristics.
The bacterial genome can reveal a lot about its actual behaviour in your product: whether it has the potential to produce toxic products, survive treatments with antibiotics or produce antimicrobial compounds. Before subjecting your probiotic strains to expensive and lengthy experimentation on health benefit substantiating properties, an in silico genome assessment can provide you with the most important first insight: is the strain safe for application?
NIZO offers a fast and automated genome assessment service, specifically designed to provide you with a clear overview of the genomic potential of your strains, in the areas of:
By selecting this service, you will obtain:
Through this service, you will be able to make an informed selection on which strains are most suitable to follow up on, in more extensive and in-depth characterization studies.
As an add-on to this automated service, NIZO can support you further with a full in silico characterization of your (foreseen) probiotic strains, for instance: